Western Michigan University   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Kalamazoo MI United States (1903)

Organization Overview

First Clinical Trial
2006
NCT00367302
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Western Michigan University | Western Michigan University School of Medicine

Active Ingredients

Drugs in Phase 4 Trials (3)

haloperidol (haldol) (2 trials)

naltrexone (revia) (1 trial)

ondansetron (zofran) (1 trial)

Drugs in Phase 2 Trials (4)

buprenorphine (1 trial)

icosapent ethyl (vascepa) (1 trial)

methadone (methadose) (1 trial)

wheat (1 trial)

Drugs in Other Trials (2)

creatine (1 trial)

maltodextrin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Behavior, Addictive (Phase 2)

Headache (Phase 4)

Inflammation (Phase 2)

Migraine Disorders (Phase 4)

Myalgia (Phase 2)

Myositis (Phase 2)

Opioid-Related Disorders (Phase 2)

Self-Injurious Behavior (Phase 4)

Self Mutilation (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 9